曼恩凱德生物醫療MNKD
那斯達克 · USD
3.78
-0.09
(-2.33%)
收盤 08/01 03:59 (UTC+8)
盤後
0
0
(0%)
08/01 03:59 (UTC+8)
曼恩凱德生物醫療MNKD
3.78
-0.09
(-2.33%)
財務數據
損益表
- 0.36
- 0.41
- 0.49
- 0.51
- 0.58
- 0.66
- 0.72
- 0.70
- 0.77
- 0.78
- 9.85
- 12.67
- 19.65
- 5.43
- 14.09
- 13.32
- 9.24
- -3.19
- 9.56
- 2.06
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 78,354 | 76,776 | 70,079 | 72,386 | 66,263 | 58,472 | 51,253 | 48,611 | 40,626 | 36,059 |
營業成本 | 17,516 | 19,604 | 18,023 | 20,377 | 18,598 | 18,067 | 14,254 | 14,237 | 16,213 | 16,124 |
營業毛利 | 60,838 | 57,172 | 52,056 | 52,009 | 47,665 | 40,405 | 36,999 | 34,374 | 24,413 | 19,935 |
營業費用 | 36,036 | 35,110 | 36,842 | 35,928 | 32,342 | 29,771 | 33,967 | 32,402 | 29,457 | 29,251 |
研發費用 | 11,022 | 11,138 | 12,926 | 11,816 | 10,013 | 9,236 | 9,989 | 6,453 | 5,605 | 7,156 |
推銷及管理費用 | 25,014 | 23,972 | 23,916 | 24,112 | 22,329 | 20,535 | 23,978 | 25,949 | 23,852 | 22,095 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 22,293 | 26,495 | 12,760 | 16,610 | 16,722 | 7,858 | 5,097 | 1,721 | -5,998 | -12,790 |
其他收入及費用 | -553 | -6,136 | 6,016 | -4,894 | 4,833 | -2,317 | 3,963 | 2,085 | 459 | -3,344 |
利息費用 | 10,632 | 7,481 | 8,360 | 12,878 | 9,262 | 5,355 | 5,274 | 9,322 | 5,210 | 5,287 |
稅前純益 | 13,617 | 8,445 | 12,870 | -1,691 | 10,894 | 2,962 | 1,721 | -5,265 | -9,795 | -17,947 |
所得稅 | 459 | 1,023 | 1,320 | 323 | 264 | 1,561 | - | - | - | - |
稅後純益 | 13,158 | 7,422 | 11,550 | -2,014 | 10,630 | 1,401 | 1,721 | -5,265 | -9,795 | -17,947 |
基本每股稅後盈餘(元) | 0.04 | 0.03 | 0.04 | -0.01 | 0.04 | - | 0.01 | -0.02 | -0.04 | -0.07 |
稀釋每股稅後盈餘(元) | 0.04 | 0.03 | 0.04 | -0.01 | 0.04 | 0.01 | 0.01 | -0.02 | -0.04 | -0.07 |
基本平均股數(千股) | 303481.00 | 279191.00 | 274998.00 | 273056.00 | 270356.00 | - | 268732.00 | 265626.00 | 263969.00 | 263378.00 |
稀釋平均股數(千股) | 320897.00 | 290631.00 | 284693.00 | 273056.00 | 324733.00 | - | 323770.00 | 265626.00 | 263969.00 | 263378.00 |
還原基本每股稅後盈餘(元) | 0.04 | 0.03 | 0.04 | -0.01 | 0.04 | - | 0.01 | -0.02 | -0.04 | -0.07 |
還原稀釋每股稅後盈餘(元) | 0.04 | 0.03 | 0.04 | -0.01 | 0.04 | 0.01 | 0.01 | -0.02 | -0.04 | -0.07 |
還原基本平均股數(千股) | 303,481 | 279,191 | 274,998 | 273,056 | 270,356 | - | 268,732 | 265,626 | 263,969 | 263,378 |
還原稀釋平均股數(千股) | 320,897 | 290,631 | 284,693 | 273,056 | 324,733 | - | 323,770 | 265,626 | 263,969 | 263,378 |
EBITDA(千元) | 26,089 | 17,600 | 22,603 | 12,527 | 21,362 | 9,875 | 9,056 | 5,963 | -2,720 | -10,079 |